# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Iridocorneal endothelial syndrome

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-4 of 4 results.
Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Sep 01, 2017
Disease(s): Glaucoma
Locations: Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China
A Phase 1/ Phase 2 Study of TTHX1114(NM141)
Status: Recruiting
Last Changed: Sep 25, 2020
First Received: Aug 20, 2020
Disease(s): Corneal Endothelial Dystrophy, Fuchs Endothelial Corneal Dystrophy, Pseudophakic Bullous Keratopathy, Endothelial Dysfunction
Intervention(s): TTHX1114(NM141), Vehicle (placebo)
Locations: North Bay Eye Associates, Inc., Petaluma, California, United States
Levenson Eye Associates, Inc, Jacksonville, Florida, United States
Chicago Corneal Consultants, Hoffman Estates, Illinois, United States
Price Vision Group, Indianapolis, Indiana, United States
Tauber Eye Center, Kansas City, Missouri, United States
... and 2 other locations.
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Status: Not yet recruiting
Last Changed: Jun 19, 2020
First Received: Jun 19, 2020
Disease(s): Fuchs Endothelial Corneal Dystrophy
Intervention(s): N-acetyl cysteine (NAC) 10% solution, N-acetyl cysteine (NAC) 20% solution, Visine Dry Eye Relief eye drops
Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis
Status: Recruiting
Last Changed: Oct 05, 2020
First Received: Jan 31, 2020
Disease(s): Fuchs' Endothelial Corneal Dystrophy
Intervention(s): K-321 Solution, Placebo Solution
Locations: Gorovoy MD Eye Specialists, Fort Myers, Florida, United States
Chicago Cornea Consultants Ltd, Hoffman Estates, Illinois, United States
Arbor Centers For Eyecare, Orland Park, Illinois, United States
Price Vision Group, Indianapolis, Indiana, United States
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
... and 18 other locations.